437 related articles for article (PubMed ID: 18191971)
1. Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children.
Vien NC; Feroldi E; Lang J
Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):294-6. PubMed ID: 18191971
[TBL] [Abstract][Full Text] [Related]
2. Pre-exposure purified vero cell rabies vaccine and concomitant routine childhood vaccinations: 5-year post-vaccination follow-up study of an infant cohort in Vietnam.
Lang J; Feroldi E; Vien NC
J Trop Pediatr; 2009 Feb; 55(1):26-31. PubMed ID: 18048461
[TBL] [Abstract][Full Text] [Related]
3. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
[TBL] [Abstract][Full Text] [Related]
4. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
[TBL] [Abstract][Full Text] [Related]
5. Boosting effect of purified chick embryo cell rabies vaccine using the intradermal route in persons previously immunized by the intramuscular route or vice versa.
Sudarshan MK; Madhusudana SN; Mahendra BJ; Narayana DH; Giri MS; Muhamuda K; Ravish HS; Venkatesh GM
Natl Med J India; 2006; 19(4):192-4. PubMed ID: 17100105
[TBL] [Abstract][Full Text] [Related]
6. Rabies antibody seroprotection rates among travelers in Nepal: "rabies seroprotection in travelers".
Ranney M; Partridge R; Jay GD; Rozzoli DE; Pandey P
J Travel Med; 2006; 13(6):329-33. PubMed ID: 17107424
[TBL] [Abstract][Full Text] [Related]
7. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety study of Indirab: a Vero cell based chromatographically purified human rabies vaccine.
Sampath G; Madhusudana SN; Sudarshan MK; Ashwathnarayana DH; Mahendra BJ; Ullas TP; Mohan K; Madhusudhan SK; Ravish HS
Vaccine; 2010 May; 28(24):4086-90. PubMed ID: 20403351
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV).
Lang J; Cetre JC; Picot N; Lanta M; Briantais P; Vital S; Le Mener V; Lutsch C; Rotivel Y
Biologicals; 1998 Dec; 26(4):299-308. PubMed ID: 10403033
[TBL] [Abstract][Full Text] [Related]
10. Serologic response to rabies pre-exposure vaccination in persons with potential occupational exposure in Singapore.
Lim PL; Barkham TM
Int J Infect Dis; 2010 Jun; 14(6):e511-3. PubMed ID: 20018545
[TBL] [Abstract][Full Text] [Related]
11. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.
Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T
Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149
[TBL] [Abstract][Full Text] [Related]
12. An immunogenicity study of a newly introduced purified Vero cell rabies vaccine (Abhayrab) manufactured in India.
Sampath G; Reddy SV; Rao ML; Rao YU; Palaniappan C
Vaccine; 2005 Jan; 23(7):897-900. PubMed ID: 15603890
[TBL] [Abstract][Full Text] [Related]
13. Postexposure rabies prophylaxis completed in 1 week: preliminary study.
Shantavasinkul P; Tantawichien T; Wilde H; Sawangvaree A; Kumchat A; Ruksaket N; Lohsoonthorn V; Khawplod P; Tantawichien T
Clin Infect Dis; 2010 Jan; 50(1):56-60. PubMed ID: 19995217
[TBL] [Abstract][Full Text] [Related]
14. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine.
Tantawichien T; Benjavongkulchai M; Limsuwan K; Khawplod P; Kaewchompoo W; Chomchey P; Sitprija V
Clin Infect Dis; 1999 May; 28(5):1100-3. PubMed ID: 10452642
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine.
Deshpande AK; Londhe VA; Akarte S; Briggs D
J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031
[TBL] [Abstract][Full Text] [Related]
16. One or three intradermal injections within one week for rabies pre-exposure immunization.
Khawplod P; Wilde H; Sriaroon C; Chomchey P; Kamolthum T; Sitprija V
Dev Biol (Basel); 2008; 131():393-401. PubMed ID: 18634501
[TBL] [Abstract][Full Text] [Related]
17. Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe.
Kamoltham T; Thinyounyong W; Phongchamnaphai P; Phraisuwan P; Khawplod P; Banzhoff A; Malerczyk C
J Pediatr; 2007 Aug; 151(2):173-7. PubMed ID: 17643772
[TBL] [Abstract][Full Text] [Related]
18. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine.
Malerczyk C; Briggs DJ; Dreesen DW; Banzhoff A
J Travel Med; 2007; 14(1):63-4. PubMed ID: 17241256
[No Abstract] [Full Text] [Related]
19. Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults.
Roukens AH; Vossen AC; van Dissel JT; Visser LG
Vaccine; 2008 Jun; 26(27-28):3438-42. PubMed ID: 18511158
[TBL] [Abstract][Full Text] [Related]
20. A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine.
Pengsaa K; Limkittikul K; Sabchareon A; Ariyasriwatana C; Chanthavanich P; Attanath P; Malerczyk C
Pediatr Infect Dis J; 2009 Apr; 28(4):335-7. PubMed ID: 19333080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
